Gravholt, Claus H;
Andersen, Niels H;
Christin-Maitre, Sophie;
Davis, Shanlee M;
Duijnhouwer, Anthonie;
Gawlik, Aneta;
Maciel-Guerra, Andrea T;
Gutmark-Little, Iris;
Fleischer, Kathrin;
Hong, David;
Klein, Karen O;
Prakash, Siddharth K;
Kanakatti Shankar, Roopa;
Sandberg, David E;
Sas, Theo C. J;
Skakkebæk, Anne;
Stochholm, Kirstine;
van der Velden, Janielle A.
Turner syndrome (TS) affects 50 per 100 000 females. TS affects multiple organs through all stages of life, necessitating multidisciplinary care. This guideline extends previous ones and includes important new advances, within diagnostics and genetics, estrogen treatment, fertility, co-morbidities, and n...
Tento KDP se zabývá následujícími oblastmi:
Diagnostika diabetu a prediabetu,
Stanovení kardiovaskulárního rizika u pacientů s diabetem a prediabetem,
Prevence kardiovaskulárních onemocnění u pacientů s diabetem a prediabetem,
Léčba ischemické choroby srdeční,
Srdeční selhání a di...
A clinical summary of this KDP was published in the Journal of the Ministry of Health of the Czech Republic .
This clinical guideline addresses a comprehensive approach aimed at the primary prevention of cardiovascular disease. Based on the epidemiological analysis and conclusions that present a gradua...
The Committee on Dyslipidemia of Korean Pediatric and Adolescents of the Korean Society of Pediatric Endocrinology has newly developed evidence-based clinical practice guidelines for dyslipidemia in Korean children and adolescents. These guidelines were formulated with the Grading of Recommendations, whi...
O'Malley, Patrick G;
Arnold, Michael J;
Pharm, Cathy Kelley;
Spacek, Lance;
Buelt, Andrew;
Natarajan, Sundar;
Donahue, Mark P;
Vagichev, Elena;
Ballard-Hernandez, Jennifer;
Logan, Amanda;
Thomas, Lauren;
Ritter, Joan;
Neubauer, Brian E;
Downs, John R.
In June 2020, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) released a joint update of their clinical practice guideline for managing dyslipidemia to reduce cardiovascular disease risk in adults. This synopsis describes the major recommendations. The guideline panel de...
Chronic pain patients require continuity of care even during the COVID-19 pandemic, which has drastically changed healthcare and other societal practices. The American Society of Interventional Pain Physicians (ASIPP) has created the COVID-ASIPP Risk Mitigation and Stratification (COVID-ARMS) Return to P...
Infections à coronavirus/complications,
Betacoronavirus,
Facteurs de risque,
Maladies cardiovasculaires/complications,
Hypertension artérielle,
Diabète,
Obésité,
Stéroïdes,
Gestion de la douleur,
Maladie chronique,
Pneumopathie virale/complications
Tobe, Sheldon;
Stone, James;
Anderson, Todd;
Bacon, Simon;
Cheng, Alice;
Daskalopoulou, Stella;
Ezekpwitz, Justin;
Gregoire, Jean;
Gubitz, Gord;
Jain, Rahul;
Keshavjee, Karim;
Lindsay, Patty;
L’Abbé, Mary;
Lau, David C. W;
Leiter, Lawrence A;
O’Meara, Eileen;
Pearson, Glen J;
Rabi, Doreen M;
Sherifali, Diana;
Selby, Peter;
Tu, Jack V;
Wharton, Sean;
Walker, Kimberly M;
Hua-Stewart, Diane;
Liu, Peter P.
This guideline is directed to primary health care providers caring for Canadian adults who have or are at risk of developing chronic cardiovascular diseases, including hypertension, diabetes, dyslipidemia, heart failure and stroke, and the risk factors for these conditions, including smoking, obesity and...
DESCRIPTION: The American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) jointly developed this guideline to present the evidence and provide clinical recommendations based on the benefits and harms of higher versus lower blood pressure targets for the treatment of hyper...
La Guía de Práctica Clínica (GPC) tiene como misión elaborar recomendaciones que sirvan de ayuda a los profesionales sanitarios del Sistema Nacional de Salud (SNS) en la toma de decisiones para el manejo de los lípidos como factor de Riesgo Cardiovascular. En esta GPC no se abordan los siguientes as...
Maladies cardiovasculaires/étiologie,
Régime alimentaire/effets indésirables,
Hydrates de carbone alimentaires/administration et posologie,
Métabolisme lipidique/physiologie,
Maladies cardiovasculaires/sang,
Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/usage thérapeutique,
Exercice physique/physiologie,
Diabète/étiologie,
Hydrates de carbone alimentaires/effets indésirables,
Matières grasses alimentaires/administration et posologie,
Matières grasses alimentaires/effets indésirables,
Dyslipidémies/étiologie,
Dyslipidémies/métabolisme,
Obésité/complications,
Obésité/prévention et contrôle,
Facteurs de risque,
Approche GRADE,
Lipides/sang,
Marqueurs biologiques/sang
This guideline covers the assessment and care of adults who are at risk of or who have cardiovascular disease (CVD), such as heart disease and stroke. It aims to help healthcare professionals identify people who are at risk of cardiovascular problems including people with type 1 or type 2 diabetes, or ch...
